Transferrin fusion protein libraries

Details for Australian Patent Application No. 2007331195 (hide)

Owner BioRexis Pharmaceutical Corporation

Inventors Wang, Baiyang; Turner, Andrew John

Agent Spruson & Ferguson

Pub. Number AU-A-2007331195

PCT Pub. Number WO2008/072075

Priority 60/934,951 12.12.06 US

Filing date 7 December 2007

Wipo publication date 19 June 2008

International Classifications

C07K 14/76 (2006.01) Peptides having more than 20 amino acids

C07K 14/79 (2006.01) Peptides having more than 20 amino acids

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/072075 Priority application(s): WO2008/072075

26 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007331199-Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6methyl-2-oxopyridin-1 (2H)-yl)-N,4-dimethylbenzamide

2007331178-Umbrella